AR064715A1 - Composiciones farmaceuticas inyecatbles liofilizadas de derivados semi- sinteticos de los alcaloides de vinca estables a temperatura ambiente - Google Patents
Composiciones farmaceuticas inyecatbles liofilizadas de derivados semi- sinteticos de los alcaloides de vinca estables a temperatura ambienteInfo
- Publication number
- AR064715A1 AR064715A1 ARP070105992A ARP070105992A AR064715A1 AR 064715 A1 AR064715 A1 AR 064715A1 AR P070105992 A ARP070105992 A AR P070105992A AR P070105992 A ARP070105992 A AR P070105992A AR 064715 A1 AR064715 A1 AR 064715A1
- Authority
- AR
- Argentina
- Prior art keywords
- semi
- stable
- pharmaceutical compositions
- liofilized
- synthetic derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Composiciones farmacéuticas que comprenden un derivado hidrosoluble semi-sintético del alcaloide de la vinca, estables a la temperatura ambiente, en los cuales dicho derivado está presente bajo la forma de un liofilizado obtenido en presencia de por lo menos un carbohidrato. Reivindicacion 3: Composiciones de acuerdo a la reivindicacion 2, caracterizadas en que la sal hidrosoluble de los derivados semi-sintéticos del alcaloide de la vinca es una sal de vinfluvina o de vinorelbina. Reivindicacion 5: Composiciones de acuerdo de una de las reivindicaciones 1 a 4, caracterizadas en que el/los carbohidrato(s) es(son) elegido(s) entre los monosacáridos, reducidos o no, los oligosacáridos y los polisacáridos tales como la inulina, y más particularmente los disacáridos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0656044A FR2910812B1 (fr) | 2006-12-29 | 2006-12-29 | Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante |
US89705907P | 2007-01-24 | 2007-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064715A1 true AR064715A1 (es) | 2009-04-22 |
Family
ID=38293420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105992A AR064715A1 (es) | 2006-12-29 | 2007-12-28 | Composiciones farmaceuticas inyecatbles liofilizadas de derivados semi- sinteticos de los alcaloides de vinca estables a temperatura ambiente |
Country Status (24)
Country | Link |
---|---|
US (1) | US8304424B2 (es) |
EP (1) | EP2120934B1 (es) |
JP (1) | JP2010514737A (es) |
KR (1) | KR20090097883A (es) |
CN (1) | CN101534821B (es) |
AR (1) | AR064715A1 (es) |
AU (1) | AU2007341231B2 (es) |
BR (1) | BRPI0722076A2 (es) |
CA (1) | CA2673232A1 (es) |
CL (1) | CL2007003838A1 (es) |
FR (1) | FR2910812B1 (es) |
HK (1) | HK1130439A1 (es) |
IL (1) | IL199556A (es) |
MA (1) | MA30892B1 (es) |
MX (1) | MX2009006949A (es) |
NO (1) | NO20092726L (es) |
NZ (1) | NZ576583A (es) |
RU (1) | RU2449791C2 (es) |
SA (1) | SA07280720B1 (es) |
TN (1) | TN2009000258A1 (es) |
TW (1) | TWI415631B (es) |
UA (1) | UA96977C2 (es) |
WO (1) | WO2008080968A1 (es) |
ZA (1) | ZA200903115B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102151249A (zh) * | 2010-02-11 | 2011-08-17 | 石药集团中奇制药技术(石家庄)有限公司 | 一种长春氟宁的药用组合物 |
JO3112B1 (ar) * | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
CN102772373B (zh) * | 2011-05-11 | 2015-09-02 | 石药集团中奇制药技术(石家庄)有限公司 | 一种注射用酒石酸长春瑞滨粉针剂及其制备方法 |
US11806642B2 (en) * | 2018-08-31 | 2023-11-07 | FUJIFILM Irvine Scientific, Inc. | Venting system for a mixing apparatus |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1170152B (it) * | 1982-07-19 | 1987-06-03 | Lilly Co Eli | Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi |
US4619935A (en) * | 1983-03-17 | 1986-10-28 | Eli Lilly And Company | Stable oncolytic formulations |
US4923876A (en) * | 1988-04-18 | 1990-05-08 | Cetus Corporation | Vinca alkaloid pharmaceutical compositions |
IL93986A0 (en) * | 1989-04-04 | 1991-01-31 | Lilly Co Eli | Improvements in and relating to pharmaceutical formulations |
US6143276A (en) * | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
FR2761990B1 (fr) * | 1997-04-10 | 1999-06-25 | Pf Medicament | Derives halogenes antimitotiques d'alcaloides de vinca |
CN101172104B (zh) * | 2002-02-22 | 2013-04-03 | 默沙东公司 | 抗肿瘤剂,特别是替莫唑胺的药物制剂,其制备方法和用途 |
FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
CN107811971B (zh) * | 2004-05-03 | 2021-10-29 | 益普生生物制药公司 | 用于药物输送的脂质体 |
TW200700092A (en) * | 2005-03-14 | 2007-01-01 | Wyeth Corp | Tigecycline compositions and methods of preparation |
-
2006
- 2006-12-29 FR FR0656044A patent/FR2910812B1/fr active Active
-
2007
- 2007-12-25 TW TW096149863A patent/TWI415631B/zh not_active IP Right Cessation
- 2007-12-27 CL CL200703838A patent/CL2007003838A1/es unknown
- 2007-12-28 MX MX2009006949A patent/MX2009006949A/es active IP Right Grant
- 2007-12-28 BR BRPI0722076-6A2A patent/BRPI0722076A2/pt not_active IP Right Cessation
- 2007-12-28 US US12/514,668 patent/US8304424B2/en active Active
- 2007-12-28 CN CN2007800423856A patent/CN101534821B/zh not_active Expired - Fee Related
- 2007-12-28 EP EP07866320.0A patent/EP2120934B1/en active Active
- 2007-12-28 KR KR1020097012321A patent/KR20090097883A/ko not_active Application Discontinuation
- 2007-12-28 CA CA002673232A patent/CA2673232A1/en not_active Abandoned
- 2007-12-28 AU AU2007341231A patent/AU2007341231B2/en not_active Ceased
- 2007-12-28 AR ARP070105992A patent/AR064715A1/es unknown
- 2007-12-28 UA UAA200907929A patent/UA96977C2/ru unknown
- 2007-12-28 NZ NZ576583A patent/NZ576583A/en not_active IP Right Cessation
- 2007-12-28 RU RU2009128327/15A patent/RU2449791C2/ru not_active IP Right Cessation
- 2007-12-28 WO PCT/EP2007/064612 patent/WO2008080968A1/en active Application Filing
- 2007-12-28 JP JP2009543478A patent/JP2010514737A/ja active Pending
- 2007-12-29 SA SA7280720A patent/SA07280720B1/ar unknown
-
2009
- 2009-05-06 ZA ZA200903115A patent/ZA200903115B/xx unknown
- 2009-05-14 MA MA31876A patent/MA30892B1/fr unknown
- 2009-06-23 TN TNP2009000258A patent/TN2009000258A1/fr unknown
- 2009-06-25 IL IL199556A patent/IL199556A/en not_active IP Right Cessation
- 2009-07-20 NO NO20092726A patent/NO20092726L/no not_active Application Discontinuation
- 2009-11-10 HK HK09110427.3A patent/HK1130439A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI415631B (zh) | 2013-11-21 |
AU2007341231B2 (en) | 2013-03-21 |
RU2449791C2 (ru) | 2012-05-10 |
CL2007003838A1 (es) | 2008-07-04 |
TW200833369A (en) | 2008-08-16 |
TN2009000258A1 (en) | 2010-10-18 |
RU2009128327A (ru) | 2011-02-10 |
US20100087473A1 (en) | 2010-04-08 |
NO20092726L (no) | 2009-07-20 |
CN101534821A (zh) | 2009-09-16 |
UA96977C2 (ru) | 2011-12-26 |
BRPI0722076A2 (pt) | 2014-04-08 |
IL199556A (en) | 2014-09-30 |
CA2673232A1 (en) | 2008-07-10 |
ZA200903115B (en) | 2010-04-28 |
NZ576583A (en) | 2012-01-12 |
US8304424B2 (en) | 2012-11-06 |
EP2120934A1 (en) | 2009-11-25 |
SA07280720B1 (ar) | 2012-02-07 |
AU2007341231A1 (en) | 2008-07-10 |
JP2010514737A (ja) | 2010-05-06 |
FR2910812B1 (fr) | 2009-03-20 |
MX2009006949A (es) | 2009-07-14 |
MA30892B1 (fr) | 2009-11-02 |
WO2008080968A1 (en) | 2008-07-10 |
KR20090097883A (ko) | 2009-09-16 |
CN101534821B (zh) | 2012-01-25 |
EP2120934B1 (en) | 2014-05-07 |
HK1130439A1 (en) | 2009-12-31 |
FR2910812A1 (fr) | 2008-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR056055A1 (es) | Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno | |
AR090456A1 (es) | Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos | |
AR089291A1 (es) | Edulcorante natural y metodo de elaboracion | |
BR112015013124A2 (pt) | novos derivados de piridina | |
AR072212A1 (es) | Una composicion farmaceutica que comprende rebamipida | |
BR112015022782A2 (pt) | composto, composição farmacêutica, combinação, e, uso de um composto | |
BR112012013847A2 (pt) | novos derivados de indolinona ciclopropano | |
BR112012026338A2 (pt) | novos derivados de 3,3-dimetil tetrahidroquinolina | |
BRPI0916286B8 (pt) | amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica | |
NI200800318A (es) | Composiciones farmacéuticas estabilizadas que comprenden fesoterodina. | |
AR064715A1 (es) | Composiciones farmaceuticas inyecatbles liofilizadas de derivados semi- sinteticos de los alcaloides de vinca estables a temperatura ambiente | |
GT200600084A (es) | Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
BR112014014184A2 (pt) | triazolopiridinas substituídas e seu uso como inibidores de ttk | |
BR112015029853A2 (pt) | uso de uma composição farmacêutica | |
MX2015006124A (es) | Inhibidores del contransportador 1 de sodio glucosa. | |
CO6640246A2 (es) | Forma cristalina del inhibidor sglt2 bencilbenceno | |
CO6270306A2 (es) | Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo | |
CO6400185A2 (es) | Formas de dosificación sólida de bendamustina | |
BRPI0818541B8 (pt) | composição farmacêutica que compreende grânulos incluindo picossulfato de sódio e bicarbonato de potássio e seu processo para a preparação | |
BR112014020416A2 (pt) | Sal de 1-(2-desoxi-2-flúor-4-tio-b-d-arabinofuranosil) citosina | |
AR056835A1 (es) | Composicion que contiene oligosacaridos | |
BR112015013783A2 (pt) | quitina ou seus derivados para a prevenção e / ou tratamento de parasitoses | |
BR112015027396A8 (pt) | derivados de purina como agonistas do receptor de cb2 | |
UY31138A1 (es) | Derivados de indolinonas sustituidas, composiciones conteniendolos y aplicaciones | |
BR112012023623A2 (pt) | agentes osmóticos de polissacarídeos esterificados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |